AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Basedow Disease

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease NCT07262476Phase 31 site๐Ÿ“ Shanghai Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy NCT06590220n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease NCT07480720n/a1 site๐Ÿ“ ElรขzฤฑฤŸ Elazฤฑg Fethi Sekin Sehir Hastanesi Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease NCT07129642EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Allogeneic CAR-T A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease NCT06984627Phase 224 sites๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires๐Ÿ“ Cรณrdoba Sanofi ยท Tests: Rilzabrutinib dose 1, Rilzabrutinib dose 2 Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease NCT06081439n/a1 site๐Ÿ“ Gothenburg Vastra Gotaland Region Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease NCT07661056Phase 356 sites๐Ÿ“ Tucson๐Ÿ“ Burbank๐Ÿ“ Huntington Beach Biohaven Therapeutics Ltd. ยท Tests: BHV-1300, Placebo Study of BHV-1300 in Graves' Disease NCT06980649Phase 118 sites๐Ÿ“ South Gate๐Ÿ“ Miami๐Ÿ“ Columbus Biohaven Therapeutics Ltd. ยท Tests: BHV-1300 Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules NCT07046546NA1 site๐Ÿ“ Reading Royal Berkshire NHS Foundation Trust ยท Tests: Thyroid artery embolization Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease NCT07547930Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Tofacitinib Preoperative Corticosteroids in Autoimmune Thyroid Disease NCT05435547Phase 43 sites๐Ÿ“ Indianapolis๐Ÿ“ Indianapolis๐Ÿ“ Indianapolis Indiana University ยท Tests: Dexamethasone, Placebo Bimatoprost as a Treatment for Graves' Orbitopathy NCT03708627EARLY Phase 11 site๐Ÿ“ Seattle Johns Hopkins University ยท Tests: Bimatoprost Ophthalmic Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease NCT07885605Phase 13 sites๐Ÿ“ Orland Park๐Ÿ“ Las Vegas๐Ÿ“ Wilmington Ethyreal Bio, Inc. ยท Tests: ETHY-001, Placebo Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease NCT07400757NA1 site๐Ÿ“ Taipei Taipei Veterans General Hospital, Taiwan ยท Tests: Atorvastatin (Lipitor), Vitamin D Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. NCT07152366Phase 41 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: IBI311, Glucocorticoids A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease NCT07265258Phase 41 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: Teprotumumab N01, Methylprednisolone Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter NCT04856488Phase 31 site๐Ÿ“ Solna Jan Calissendorff ยท Tests: Iodine-Potassium Iodide 5%-10% Oral and Topical Solution Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment NCT07117981n/a9 sites๐Ÿ“ Paris๐Ÿ“ Caen๐Ÿ“ Lyon Centre Hospitalier National d'Ophtalmologie des Quinze-Vingโ€ฆ Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease NCT04936854Phase 21 site๐Ÿ“ Bergen Haukeland University Hospital ยท Tests: Sirolimus 1 mg Oral Tablet, Methylprednisolone A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease NCT07113262Phase 31 site๐Ÿ“ Shenyang Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI311, Placebo Course for Brain Fatigue After Graves' Disease Controlled Study NCT06134219NA1 site๐Ÿ“ Gothenburg Vastra Gotaland Region ยท Tests: MF course, Usual health care The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. NCT07152340Phase 42 sites๐Ÿ“ Changhua๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: IBI311, Glucocorticoids Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis NCT06963203n/a15 sites๐Ÿ“ Aalst๐Ÿ“ Nancy๐Ÿ“ Athens Andrea Goldmann Treatment of Chronic Thyroid Eye Disease With MHB018A NCT07622121Phase 31 site๐Ÿ“ Coral Gables Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection, MHB018A injection Placebo An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease NCT07438405Phase 28 sites๐Ÿ“ Little Rock๐Ÿ“ Kissimmee๐Ÿ“ Orland Park Amgen ยท Tests: AMG 732 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease NCT07570316Phase 332 sites๐Ÿ“ Orange๐Ÿ“ Pasadena๐Ÿ“ Pasadena argenx ยท Tests: Efgartigimod PH20 SC, Placebo PH20 SC A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease NCT06727604Phase 2134 sites๐Ÿ“ Phoenix๐Ÿ“ Phoenix๐Ÿ“ Huntington Beach Immunovant Sciences GmbH ยท Tests: IMVT-1402, IMVT-1402, Placebo Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease NCT07812194n/a1 site๐Ÿ“ Herlev University of Copenhagen ยท Tests: Study-related ophthalmological assessment and biospecimen collection, Blood biomarkers and standardized blood samples iโ€ฆ Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial) NCT06392906Phase 31 site๐Ÿ“ Bangkok Noi Janjira Petsuksiri ยท Tests: Short course radiation therapy, Standard course radiation therapy Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease NCT07400224Phase 1, Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Al18F-NOTA-FAPI PET/CT(or PET/MRI)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy